PubRank

J Reyes

Author PubWeight™ 209.11‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intestinal transplantation in composite visceral grafts or alone. Ann Surg 1992 4.96
2 Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995 2.95
3 Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000 2.91
4 Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation 1992 2.75
5 The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med 1995 2.68
6 Management of intestinal transplantation in humans. Transplant Proc 1992 2.62
7 Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 1998 2.31
8 Three years clinical experience with intestinal transplantation. J Am Coll Surg 1994 2.20
9 Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol 1997 2.05
10 Pathology of human intestinal transplantation. Gastroenterology 1996 1.98
11 Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg 1992 1.85
12 Effect of the anesthetics benzyl alcohol and chloroform on bilayers made from monolayers. Biophys J 1979 1.78
13 Monitoring and treatment of intestinal allograft rejection in humans. Transplant Proc 1993 1.78
14 Use of FK 506 in pediatric patients. Transplant Proc 1991 1.77
15 Small intestinal transplantation in humans with or without the colon. Transplantation 1994 1.74
16 Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned? J Clin Endocrinol Metab 1997 1.68
17 Nonadherence consensus conference summary report. Am J Transplant 2009 1.61
18 Liver transplantation for polycystic liver disease. Arch Surg 1990 1.61
19 Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation 1995 1.59
20 Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995 1.59
21 Weaning of immunosuppression in liver transplant recipients. Transplantation 1997 1.57
22 Piggyback orthotopic intestinal transplantation. Surg Gynecol Obstet 1993 1.55
23 Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation 2000 1.53
24 Intestinal transplantation in children with chronic intestinal pseudo-obstruction. Gut 1999 1.52
25 Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg 2001 1.44
26 Intestinal transplantation at the University of Pittsburgh. Transplant Proc 1994 1.42
27 Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): evidence for heterogeneity. Hepatology 1997 1.41
28 Abdominal multivisceral transplantation. Transplantation 1995 1.37
29 Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease. Transplantation 1998 1.33
30 Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transplant 2001 1.32
31 Localized CT-guided irradiation inhibits neurogenesis in specific regions of the adult mouse brain. Radiat Res 2011 1.30
32 Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998 1.28
33 Clinical small bowel or small bowel plus liver transplantation under FK 506. Transplant Proc 1991 1.24
34 Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease. Transpl Infect Dis 2001 1.22
35 Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation 2003 1.18
36 Temporary end to side portacaval shunt in orthotopic hepatic transplantation in humans. Surg Gynecol Obstet 1993 1.18
37 Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. J Pediatr Surg 1999 1.14
38 Clinical intestinal transplantation: focus on complications. Transplant Proc 1992 1.11
39 Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads. J Infect Dis 2000 1.11
40 Cryptococcal meningitis after liver transplantation. Transplantation 1996 1.08
41 Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. Transplant Proc 1997 1.07
42 The nature of the voltage-dependent conductance of the hemocyanin channel. J Membr Biol 1975 1.05
43 Induction and general properties of beta-galactosidase and beta-galactoside permease in Pseudomonas BAL-31. J Bacteriol 1977 1.05
44 Bacterial translocation in clinical intestinal transplantation. Transplantation 2001 1.03
45 Percutaneous transluminal angioplasty of venous anastomotic stenoses complicating liver transplantation: intermediate-term results. J Vasc Interv Radiol 1994 1.03
46 Hepatic hemangioendothelioma: clinical experience and management strategy. J Pediatr Surg 1999 1.03
47 Changes in interfacial potentials induced by carbonylcyanide phenylhydrazone uncouplers: possible role in inhibition of mitochondrial oxygen consumption and other transport processes. Membr Biochem 1984 1.03
48 Internal hernia and volvulus of the small bowel following liver transplantation. Transpl Int 1997 1.02
49 Intestinal transplantation in children under FK 506 immunosuppression. J Pediatr Surg 1993 1.02
50 What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Ann Surg 1999 1.02
51 Endoscopies in pediatric small intestinal transplant recipients: five years experience. Am J Gastroenterol 1998 1.02
52 The phylogeography of dusky dolphins (Lagenorhynchus obscurus): a critical examination of network methods and rooting procedures. Mol Ecol 2003 1.01
53 FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication. Transplant Proc 1991 1.01
54 Apoptotic chondrocytes from osteoarthrotic human articular cartilage and abnormal calcification of subchondral bone. J Rheumatol 2000 1.01
55 Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. Transplant Proc 1996 1.00
56 Early infectious complications of liver-intestinal transplantation in children: preliminary analysis. Transplant Proc 1994 0.99
57 Rejection of human intestinal allografts: alone or in combination with the liver. Transplant Proc 1994 0.99
58 Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile. Transplant Proc 2005 0.98
59 Arterioportal fistula following liver biopsy. Three cases occurring in liver transplant recipients. Dig Dis Sci 1995 0.98
60 Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children. Transplantation 2000 0.98
61 Transplantation of human hepatocytes. Transplant Proc 1997 0.97
62 The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation. Transpl Infect Dis 2001 0.96
63 Multicentre surveillance of antimicrobial resistance in enterococci and staphylococci from Colombian hospitals, 2001-2002. J Antimicrob Chemother 2003 0.95
64 Use of indium-111-labeled hepatocytes to determine the biodistribution of transplanted hepatocytes through portal vein infusion. Clin Nucl Med 2000 0.95
65 Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr 1998 0.95
66 Factors associated with recurrent cytomegalovirus disease after small bowel transplantation. Transplant Proc 1994 0.94
67 CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Am J Transplant 2006 0.94
68 Histological criteria for the identification of acute cellular rejection in human small bowel allografts: results of the pathology workshop at the VIII International Small Bowel Transplant Symposium. Transplant Proc 2004 0.94
69 One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. Transplant Proc 1995 0.94
70 Pathology of intestinal transplantation in children. Am J Surg Pathol 1995 0.93
71 FK 506 versus cyclosporine in pediatric liver transplantation. Transplant Proc 1991 0.93
72 Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. Transplant Proc 1991 0.93
73 Cytomegalovirus infection after intestinal transplantation in children. Clin Infect Dis 1997 0.93
74 The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients. Pediatr Transplant 1999 0.93
75 Clinical intestinal transplantation. Transplant Proc 1993 0.92
76 Anatomic variability of rejection in intestinal allografts after pediatric intestinal transplantation. J Pediatr Gastroenterol Nutr 1998 0.92
77 Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation 2000 0.92
78 Risks and benefits of weaning immunosuppression in liver transplant recipients: long-term follow-up. Transplant Proc 1997 0.92
79 Evolution of clinical intestinal transplantation: improved outcome and cost effectiveness. Transplant Proc 1999 0.92
80 Fulminant hepatic failure: Wilson's disease or autoimmune hepatitis? Implications for transplantation. Pediatr Transplant 2005 0.92
81 Composite liver--small bowel allografts with preservation of donor duodenum and hepatic biliary system in children. J Pediatr Surg 2000 0.92
82 Liver transplantation for Alagille's syndrome. Arch Surg 1993 0.91
83 Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children. Transplant Proc 1996 0.91
84 [Endoscopic management of foreign bodies in the esophagus. Results of a retrospective series of 501 cases]. Gastroenterol Hepatol 2002 0.91
85 Intestinal transplantation in humans under FK 506. Transplant Proc 1993 0.90
86 Analysis of patients with longitudinal intestinal lengthening procedure referred for intestinal transplantation. J Pediatr Surg 2001 0.90
87 The growth of tissue engineering. Tissue Eng 2001 0.90
88 Intestinal transplantation and bacterial overgrowth in humans. Transplant Proc 1994 0.90
89 Membrane actions of male contraceptive gossypol tautomers. Biochim Biophys Acta 1986 0.90
90 Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatr Dev Pathol 1999 0.89
91 Molecular mechanisms of gossypol action on lipid membranes. J Biol Chem 1984 0.89
92 Nosocomial outbreak of Enteroccocus gallinarum: untaming of rare species of enterococci. J Hosp Infect 2008 0.89
93 Total serum IgE: adult reference values in Valencia (1981-2004). Usefulness in the diagnosis of allergic asthma and rhinitis. Allergol Immunopathol (Madr) 2005 0.88
94 Endorectal pull-through of transplanted colon as part of intestinal transplantation. Surgery 1995 0.88
95 Epstein-Barr virus infections in children after transplantation of the small intestine. Am J Surg Pathol 1998 0.87
96 Medical audit on asthma in an emergency department. Allergol Immunopathol (Madr) 2006 0.87
97 Thyroid nodules: sonographic-pathologic correlation. Radiology 1984 0.87
98 Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. Transplant Proc 1992 0.87
99 Small intestinal transplantation for irreversible intestinal failure in children. Dig Dis Sci 1997 0.87
100 Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation 1998 0.86
101 Adjuvant bone marrow infusion in clinical organ transplant recipients. Transplant Proc 1998 0.86
102 Liver transplantation in patients over sixty years of age. Transplantation 1991 0.86
103 Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. Transplant Proc 1999 0.86
104 Liver transplantation for neonatal hepatitis as compared to the other two leading indications for liver transplantation in children. J Hepatol 1994 0.86
105 Primary tacrolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients. Pediatr Transplant 2001 0.85
106 Sensitive reverse staining of bacterial lipopolysaccharides on polyacrylamide gels by using zinc and imidazole salts. Anal Biochem 1997 0.85
107 Coordinated interdisciplinary management of pediatric intestinal failure: a 2-year review. J Pediatr Surg 2000 0.85
108 Amiloride fluxes across erythrocyte membranes. Biochim Biophys Acta 1983 0.85
109 Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. J Pediatr Surg 1992 0.85
110 Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J Leukoc Biol 1999 0.85
111 Logistics and technique for procurement of intestinal, pancreatic, and hepatic grafts from the same donor. Ann Surg 2000 0.84
112 Single-dose pharmacokinetics of lenalidomide in healthy volunteers: dose proportionality, food effect, and racial sensitivity. Cancer Chemother Pharmacol 2012 0.84
113 Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center. Transplant Proc 2002 0.84
114 Results of simultaneous and sequential pediatric liver and kidney transplantation. Transplantation 2001 0.84
115 Parvovirus B19 infection in pediatric transplant patients. Transplantation 1993 0.84
116 Early tolerance in pediatric liver allograft recipients. J Pediatr Surg 1994 0.84
117 Noncompliance after pediatric liver transplantation. Transplant Proc 1999 0.83
118 Bacterial translocation in clinical intestinal transplantation. Transplant Proc 2000 0.83
119 "Munchausen by proxy" syndrome in a small bowel transplant recipient. Transplant Proc 1996 0.83
120 Intravenous thrombolysis in ischemic stroke with unknown onset using CT perfusion. Acta Neurol Scand 2013 0.83
121 The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc 2000 0.82
122 The efficacy of daclizumab for intestinal transplantation: preliminary report. Transplant Proc 2000 0.82
123 Pediatric solid-organ transplant recipients carry chronic loads of Epstein-Barr virus exclusively in the immunoglobulin D-negative B-cell compartment. J Clin Microbiol 2001 0.82
124 Role of endoscopy following small intestinal transplantation in children. Transplant Proc 1994 0.82
125 AIDS prevention training for pharmacy workers in Mexico City. AIDS Care 1996 0.82
126 The use of clonidine for the treatment of high intestinal output following small bowel transplantation. Transplant Proc 1997 0.82
127 PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice. Transplant Proc 2013 0.82
128 Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up. Transplant Proc 2001 0.82
129 Improving results of pediatric renal transplantation. J Am Coll Surg 1994 0.82
130 Histologic monitoring of human small bowel allografts with clinical correlation. Transplant Proc 1992 0.81
131 Causes of retransplantation after primary liver transplantation in 4000 consecutive patients: 2 to 19 years follow-up. Transplant Proc 2001 0.81
132 Use of intrahepatic chemotherapy to treat advanced pediatric hepatic malignancies. J Pediatr Gastroenterol Nutr 2000 0.81
133 Intrahepatic chemoembolization in unresectable pediatric liver malignancies. Pediatr Radiol 2000 0.81
134 Secondary structure prediction of the hemagglutinin-neuraminidase from a porcine rubulavirus. Arch Virol 1998 0.80
135 Immunoelectron microscopy of PCNA as an efficient marker for studying replication times and sites during pollen development. Chromosoma 2000 0.80
136 Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc 1998 0.80
137 Comparison of intravenous ganciclovir followed by oral acyclovir with intravenous ganciclovir alone for prevention of cytomegalovirus and Epstein-Barr virus disease after liver transplantation in children. Clin Infect Dis 1997 0.80
138 An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation 1999 0.80
139 Late severe rejection of intestinal allografts: risks and survival outcome. Transplant Proc 2001 0.80
140 Transhepatic insertion of vascular dialysis catheters in children: a safe, life-prolonging procedure. Pediatr Radiol 1999 0.80
141 Generation and characterization of a human monoclonal autoantibody that acts as a high affinity interleukin-1 alpha specific inhibitor. Mol Immunol 1996 0.80
142 Hyperbaric oxygen therapy for hepatic artery thrombosis after liver transplantation in children. Liver Transpl Surg 1999 0.80
143 Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease. Transplantation 2000 0.80
144 Intestinal transplantation in children after primary liver transplantation. Transplant Proc 1998 0.80
145 Surface potentials and sodium entry in frog skin epithelium. J Physiol 1981 0.80
146 Long term management of liver transplant rejection in children. BioDrugs 2000 0.79
147 Use of cyclosporin-A in experimental spinal cord injury: design of a dosing strategy to maintain therapeutic levels. J Neurotrauma 1996 0.79
148 Rituximab in the treatment of pediatric small bowel transplant patients with posttransplant lymphoproliferative disorder unresponsive to standard treatment. Transplant Proc 2002 0.79
149 Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation 2001 0.79
150 Pharmacodynamics of sirolimus in transplanted children receiving tacrolimus. Transplant Proc 2002 0.79
151 Bulk milk urea concentrations and their relationship with cow fertility in grazing dairy herds in southern Chile. Prev Vet Med 1999 0.79
152 Pediatric liver transplantation. History, recent innovations, and outlook for the future. Clin Pediatr (Phila) 1993 0.79
153 A technique for distal splenoadrenal shunting in pediatric portal hypertension. J Am Coll Surg 1998 0.79
154 Energy metabolism of cultured TM4 cells and the action of gossypol. Biol Reprod 1986 0.79
155 Two-year experience with FK 506 in pediatric patients. Transplant Proc 1993 0.78
156 Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. Transplant Proc 1992 0.78
157 Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy. J Pediatr Surg 1995 0.78
158 Management of hepatic venous obstruction after split-liver transplantation. Pediatr Transplant 2000 0.78
159 Posttransplant lymphoproliferative disorders in small bowel allograft recipients. Transplant Proc 2000 0.78
160 Current status of intestinal transplantation. Adv Surg 1994 0.78
161 Hepatic and intestinal transplantation at the University of Pittsburgh. Clin Transpl 1998 0.78
162 Successful liver transplantation for isoniazid-induced hepatic failure--a case report. Transplantation 1994 0.78
163 Cryptosporidial infections after solid organ transplantation in children. Pediatr Transplant 2000 0.78
164 Randomized trial of ganciclovir followed by high-dose oral acyclovir vs ganciclovir alone in the prevention of cytomegalovirus disease in pediatric liver transplant recipients: preliminary analysis. Transplant Proc 1994 0.78
165 Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. Transplant Proc 2000 0.78
166 Reasons why some children receiving tacrolimus therapy require steroids more than 5 years post liver transplantation. Pediatr Transplant 2001 0.78
167 Intestinal transplantation in children. Curr Gastroenterol Rep 1999 0.78
168 Gastrointestinal posttransplant lymphoproliferative disease in children after small intestinal transplantation. Transplant Proc 1996 0.78
169 Intestinal motility after small bowel transplantation. Transplant Proc 1998 0.77
170 Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. Transplantation 2001 0.77
171 Search for an IgG response against neural antigens in experimental spinal cord injury. Neuroscience 2000 0.77
172 Clinical intestinal transplantation in 1998: Pittsburgh experience. Acta Gastroenterol Belg 1999 0.77
173 Imaging in liver transplantation. Radiol Clin North Am 1996 0.77
174 Insulinlike growth factor 1 and insulinlike growth factor 3: indices of intestinal failure in children. J Pediatr Surg 1999 0.77
175 [Lactose malabsorption in ulcerative colitis. A case-control study]. Gastroenterol Hepatol 2003 0.77
176 Evolution of surgical techniques in clinical intestinal transplantation. Transplant Proc 1994 0.77
177 Clinical features of nosocomial rotavirus infection in pediatric liver transplant recipients. Clin Transplant 1995 0.77
178 [Duchenne and Becker muscular dystrophy in Chile]. Rev Med Chil 1992 0.77
179 Intestinal transplantation: 4-year experience. Transplant Proc 1995 0.77
180 Severe exfoliative rejection after intestinal transplantation in children. Transplant Proc 1996 0.77
181 Natural history of Epstein-Barr viral load in peripheral blood of pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disorder. Transplant Proc 1999 0.77
182 Eating difficulties in the pediatric small bowel recipient: the role of the nutritional management team. Transplant Proc 1994 0.77
183 Almost total absence of chronic rejection in primary pediatric liver transplantation under tacrolimus. Transplant Proc 2002 0.76
184 gammadeltaT cells are involved in liver transplant tolerance. Transplant Proc 2009 0.76
185 Infectious complications of pediatric liver transplantation under FK 506. Transplant Proc 1991 0.76
186 Isolated intestinal versus composite visceral allografts: causes of graft failure. Transplant Proc 2000 0.76
187 The current status of hepatic transplantation at the University of Pittsburgh. Clin Transpl 1995 0.76
188 Improved survival with cytomegalovirus infection after intestinal transplantation in children. Transplant Proc 1996 0.76
189 Preliminary immunosuppression withdrawal strategies with sirolimus in children with liver transplants. Transplant Proc 2002 0.76
190 Rubella infection after orthotopic liver transplantation. Pediatr Infect Dis J 1994 0.75
191 Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. Transplant Proc 1999 0.75
192 Basic considerations for the procurement of intestinal grafts. Transplant Proc 1994 0.75
193 Pittsburgh University questions paper. J Okla State Med Assoc 1995 0.75
194 Abnormal gastric emptying after intestinal transplantation. Transplant Proc 1994 0.75
195 Adaptation of split liver grafts in pediatric patients. Pediatr Transplant 2001 0.75
196 [Lupine, a contribution to the human food supply. 4. Acceptability of Lupinus alba flour]. Z Ernahrungswiss 1976 0.75
197 The long-term efficacy of multivisceral transplantation. Transplant Proc 2000 0.75
198 Pathologic analysis of recurrent posttransplant lymphoproliferative disorders. Transplant Proc 1995 0.75
199 Intestinal retransplantation. Transplant Proc 1996 0.75
200 Functional analysis of graft lamina propria associated lymphocytes from a recipient of a human cadaveric small bowel allograft primarily immunosuppressed with FK 506. Transplant Proc 1991 0.75
201 Intestinal transplantation at the University of Pittsburgh: six-year experience. Transplant Proc 1997 0.75
202 Use of the D-xylose absorption test in monitoring intestinal allografts. Transplant Proc 1994 0.75
203 Intestinal transplantation in 31 adults. Transplant Proc 1996 0.75
204 FK 506 in small bowel transplant recipients: pharmacokinetics and dosing. Transplant Proc 1994 0.75
205 Immunoreactivity of T lymphocytes propagated from biopsies of human cadaveric small intestine allografts: a serial study of four patients. Transplant Proc 1992 0.75
206 Influence of donor criteria on early outcome after intestinal transplantation. Transplant Proc 1997 0.75
207 [Colorectal trauma caused by foreign bodies]. Rev Esp Enferm Dig 2002 0.75
208 Effect of CMV serology on outcome after clinical intestinal transplantation. Transplant Proc 1996 0.75
209 Mycophenolate mofetil for treatment of chronic rejection in liver allograft under tacrolimus. Transplant Proc 2002 0.75
210 [Duchenne muscular dystrophy. Effects of vitamin E administration on urinary luminescence]. Rev Med Chil 1998 0.75
211 Histologic spectrum of acute cellular rejection in human intestinal allografts. Transplant Proc 1996 0.75
212 [A case of yellow nails syndrome]. Ann Dermatol Venereol 1984 0.75
213 [Simple radiology and angiocardiography in obstructive myocardiopathy. A study of 23 cases]. Rev Med Chil 1967 0.75
214 Modified temporary end-to-side portocaval shunt in liver and small bowel transplantation. Pediatr Transplant 2001 0.75
215 Early clinical and histologic viability of human liver-small intestinal allografts after implantation. Clin Transplant 1994 0.75
216 [Adverse reactions induced by gadopentetate dimeglumine in magnetic resonance imaging]. An Med Interna 2007 0.75
217 Lack of correlation between DNA copy number and mRNA expression levels of c-myc in gamma-radiation-induced mouse thymic lymphomas by using quantitative real-time PCR. Clin Transl Oncol 2006 0.75
218 The neuropathology of intestinal failure and small bowel transplantation. Acta Neuropathol 1999 0.75
219 [Naproxen in osteoarthritis]. Scand J Rheumatol Suppl 1973 0.75
220 The use of hepatitis B core antibody-positive donor livers does not appear to have a deleterious effect on graft survival in liver transplantation for hepatitis C. Transplant Proc 2010 0.75
221 Osteoblastic metastases from medullary carcinoma of the thyroid. Br J Radiol 1980 0.75
222 Recovery from dispositional and pharmacodynamic tolerance after chronic pentobarbital treatment. J Pharmacol Exp Ther 1985 0.75
223 [Extracorporeal dialysis in acute renal failure]. Rev Med Chil 1968 0.75
224 [Experience with chronic dialysis]. Rev Med Chil 1970 0.75
225 [Estimation of household income and percentage poor at the province and district level in Peru]. Notas Poblacion 1996 0.75
226 Nutritional monitoring of pediatric intestinal transplant recipients. Transplant Proc 1998 0.75
227 Stimulation of beta-galactoside transport in Pseudomonas BAL-31 by infection with bacteriophage PM2. FEBS Lett 1977 0.75
228 [Paraduodenal hernia: report of 2 cases]. Rev Med Chil 1984 0.75
229 Polychlorinated aromatic hydrocarbon lethality, mixed-function oxidase induction, and uroporphyrinogen decarboxylase inhibition in the chick embryo: dissociation of dose-response relationships. Toxicol Appl Pharmacol 1985 0.75
230 Patient profile and candidacy for intestinal transplantation at the University of Pittsburgh. Transplant Proc 2002 0.75
231 [Lymphocitic colitis and celiac disease]. Rev Esp Enferm Dig 2006 0.75
232 Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients. Paediatr Drugs 2001 0.75
233 Human monoclonal antibody as an interleukin-10-specific antagonist. J Interferon Res 1994 0.75
234 [The aortic arch syndrome. Clinical and aortographic study]. Rev Med Chil 1968 0.75
235 [Oral cholecystography with delayed exposure (author's transl)]. Rev Med Chil 1977 0.75
236 The rat thymus contains a heparin-binding factor that modulates steroidogenesis in the testis. Acta Physiol Pharmacol Ther Latinoam 1996 0.75
237 Coronary bypass operation for early postinfarction angina. Surg Gynecol Obstet 1983 0.75
238 [Clinical diagnosis of severe acute nonrheumatic mitral valve insufficiency]. Rev Med Chil 1972 0.75
239 STD / AIDS prevention in Mexico City. The role of pharmacies. AIDS Soc 1994 0.75
240 Ulcerative colitis after liver transplant and immunosuppression. J Pediatr Gastroenterol Nutr 1999 0.75
241 [Giant esophageal fibrovascular polyp]. Gastroenterol Hepatol 2004 0.75
242 Differential rates of ischemic cholangiopathy and graft survival associated with induction therapy in DCD liver transplantation. Am J Transplant 2015 0.75
243 Application of feces extracts and synthetic analogues of the host marking pheromone of Anastrepha ludens significantly reduces fruit infestation by A. obliqua in tropical plum and mango backyard orchards. J Econ Entomol 2009 0.75
244 Mechanism of pyrogallol red oxidation induced by free radicals and reactive oxidant species. A kinetic and spectroelectrochemistry study. J Phys Chem B 2013 0.75
245 [Arteriovenous shunt and fistula for chronic hemodialysis]. Rev Med Chil 1971 0.75
246 Differential responses of Ruta chapelensis in small intestine from male and female guinea pigs. Proc West Pharmacol Soc 1991 0.75
247 [Epigenetic role of stress of environmental origin on the etiology of diabetes (author's transl)]. Rev Med Chil 1979 0.75
248 Review of common adverse effects of selected antiarrhythmic drugs. Crit Care Nurs Q 2000 0.75
249 Pesticide inactivation of peanut glutamate dehydrogenase: biochemical basis of the enzyme's isomerization. J Agric Food Chem 1999 0.75
250 Hypotensive activity of Cecropia obtusifolia. J Pharm Sci 1982 0.75
251 Effect of supplemental yeast culture in sow gestation and lactation diets on apparent nutrient digestibilities and reproductive performance through one reproductive cycle. J Anim Sci 1995 0.75
252 [Epidemiologic aspects of strabismus in Valparaíso, Chile]. Rev Med Chil 1978 0.75
253 Monitoring of intestinal myoelectrical activity after isolated small bowel transplantation in FK 506 immunosuppressed pigs. Transplant Proc 1994 0.75
254 FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation. Bone Marrow Transplant 1995 0.75
255 [Chagas' disease in Chile. Urban sectors. X. Frequency of Chagas' infection in blood donors and in mothers and newborn infants of the cities of La Serena, Ovalle and Illapel, 1983-1985]. Bol Chil Parasitol 1986 0.75
256 Therapeutic compliance among asthma patients in an allergy clinic: third evaluation (SEGARIA Project). Allergol Immunopathol (Madr) 2006 0.75
257 What's new in pediatric organ transplantation. Pediatr Rev 1999 0.75
258 [Mitral valve replacement: 6 years experience in 119 cases (author's transl)]. Rev Med Chil 1974 0.75
259 Elevated immunoreactive trypsinogen levels in pediatric patients with short bowel syndrome. Transplant Proc 1998 0.75
260 [Isoproterenol in the hemodynamic study of obstructive heart disease]. Rev Med Chil 1968 0.75
261 Clinical intestinal transplantation. Clin Nutr 1996 0.75
262 Immunoreactive trypsinogen levels in pediatric patients with intestinal failure awaiting intestinal transplantation. Clin Transplant 1999 0.75
263 Care of the pediatric solid organ transplant recipient. The primary care perspective. Pediatr Clin North Am 1998 0.75
264 [Toxic shock. Staphylococcus aureus toxemia]. Rev Med Chil 1987 0.75
265 Intestinal transplantation with or without other abdominal organs: nutritional and dietary management of 50 patients. Transplant Proc 1994 0.75